Cyclotron production and radiochemical separation of 55Co and 58mCo from 54Fe, 58Ni and 57Fe targets von Valdovinos, H.F., Hernandez, R., Graves, S., Ellison, P.A., Barnhart, T.E., Theuer, C.P., Engle, J.W., Cai, W., Nickles, R.J.

Volltext

Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer von Paauwe, M, Heijkants, R C, Oudt, C H, van Pelt, G W, Cui, C, Theuer, C P, Hardwick, J C H, Sier, C F M, Hawinkels, L J A C

Volltext

367 A first-in-human Phase 1 study of anti-CD105 antibody therapy with TRC105 in patients with advanced solid tumors von Rosen, L, Gordon, M.S, Hurwitz, H.I, Wong, M.K, Goldman, J, Adams, B.J, Alvarez, D, Seon, B.K, Theuer, C.P, Leigh, B.R

Volltext

400 POSTER Early evidence of tolerability and clinical activity from a phase 1 study of TRC105 (anti-CD105 antibody) in patients with advanced refractory cancer von Rosen, L.S, Gordon, M.S, Hurwitz, H.I, Mendelson, D.S, Kleinzweig, D, Adams, B.J, Theuer, C.P

Volltext

414 POSTER A phase I, open-label, dose escalation study of the humanized monoclonal antibody (HuMAb) TRC093, an inhibitor of angiogenesis that binds to cleaved collagen, in patient... von Gordon, M.S, Rosen, L.S, Robert, F, Mendelson, D.S, Kleinzweig, D, Adams, B.J, Theuer, C.P

Volltext

Trc105 (Anti-Endoglin Antibody) in Combination with Bevacizumab (Bev) and As a Single Agent for Platinum Resistant Ovarian Cancer von Garcia, A.A., Makker, V., Spitz, D.L., Matei, D.E., Nick, A.M., Landen, C.N., Alvarez, E.A., Mendelson, D.S., Strother, R.M., Seon, B.K., Alvarez, D., Adams, B.J., Theuer, C.P., Gordon, M.

Volltext

887PTRC105 (ANTI-ENDOGLIN ANTIBODY) IN COMBINATION WITH BEVACIZUMAB (BEV) AND AS A SINGLE AGENT FOR PLATINUM RESISTANT OVARIAN CANCER von Garcia, A.A., Makker, V., Spitz, D.L., Matei, D.E., Nick, A.M., Landen, C.N., Alvarez, E.A., Mendelson, D.S., Strother, R.M., Seon, B.K., Alvarez, D., Adams, B.J., Theuer, C.P., Gordon, M.

Volltext

Targeting endoglin-expressing regulatory T cells in the tumor microenvironment enhances the effect of PD1 checkpoint inhibitor immunotherapy von Schoonderwoerd, M.J.A., Koops, M.F.M., Angela, R.A., Koolmoes, B., Toitou, M., Paauwe, M., Barnhoorn, M.C., Liu, Y.M., Sier, C.F.M., Hardwick, J.C.H., Nixon, A.B., Theuer, C.P., Fransen, M.F., Hawinkels, L.J.A.C.

Volltext bestellen

A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing von THEUER, CP, FITZGERALD, D, PASTAN

Volltext

Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis von Paauwe, M., Schoonderwoerd, M.J.A., Helderman, R.F.C.P., Harryvan, T.J., Groenewoud, A., Pelt, G.W. van, Bor, R., Hemmer, D.M., Versteeg, H.H., Snaar-Jagalska, B.E., Theuer, C.P., Hardwick, J.C.H., Sier, C.F.M., Dijke, P. ten, Hawinkels, L.J.A.C.

Volltext bestellen

Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis von Paauwe, M., Schoonderwoerd, M.J.A., Helderman, R.F.C.P., Harryvan, T.J., Groenewoud, A., Pelt, G.W. van, Bor, R., Hemmer, D.M., Versteeg, H.H., Snaar-Jagalska, B.E., Theuer, C.P., Hardwick, J.C.H., Sier, C.F.M., Dijke, P. ten, Hawinkels, L.J.A.C.

Volltext bestellen

Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer von Paauwe, M., Heijkants, R.C., Oudt, C.H., Pelt, G.W. van, Cui, C., Theuer, C.P., Hardwick, J.C.H., Sier, C.F.M., Hawinkels, L.J.A.C.

Volltext bestellen